Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

The New England Journal of Medicine
Teresa QuattrinRECOVERY Collaborative Group

Abstract

Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factor α that has already been approved for the treatment of several autoimmune conditions in adults and children. Whether golimumab could preserve beta-cell function in youth with newly diagnosed overt (stage 3) type 1 diabetes is unknown. In this phase 2, multicenter, placebo-controlled, double-blind, parallel-group trial, we randomly assigned, in a 2:1 ratio, children and young adults (age range, 6 to 21 years) with newly diagnosed overt type 1 diabetes to receive subcutaneous golimumab or placebo for 52 weeks. The primary end point was endogenous insulin production, as assessed according to the area under the concentration-time curve for C-peptide level in response to a 4-hour mixed-meal tolerance test (4-hour C-peptide AUC) at week 52. Secondary and additional end points included insulin use, the glycated hemoglobin level, the number of hypoglycemic events, the ratio of fasting proinsulin to C-peptide over time, and response profile. A total of 84 participants underwent randomization - 56 were assigned to the golimumab group and 28 to the placebo group. Th...Continue Reading

References

Nov 1, 1991·Clinical and Experimental Immunology·M G CavalloR Thorpe
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C O JacobH Acha-Orbea
Jun 22, 2005·Cellular and Molecular Life Sciences : CMLS·S KodamaD L Faustman
May 14, 2009·Diabetes Care·Henrik B MortensenUNKNOWN Hvidoere Study Group on Childhood Diabetes
Nov 27, 2009·The New England Journal of Medicine·Mark D PescovitzUNKNOWN Type 1 Diabetes TrialNet Anti-CD20 Study Group
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Jan 21, 2011·Physiological Reviews·Tom L van BelleMatthias G von Herrath
May 19, 2012·PloS One·Maria KoulmandaTerry B Strom
Jun 18, 2014·Diabetes Care·Jane L ChiangUNKNOWN Type 1 Diabetes Sourcebook Authors
Jul 2, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Mark R Rigby, Mario R Ehlers
Jul 21, 2015·The Journal of Clinical Investigation·Mark R RigbyMario R Ehlers
Sep 26, 2015·Diabetes Care·Diane K WherrettUNKNOWN Type 1 Diabetes TrialNet Study Group
Aug 20, 2016·Current Diabetes Reports·Raghavendra G MirmiraCarmella Evans-Molina
Apr 14, 2017·The New England Journal of Medicine·Elizabeth J Mayer-DavisUNKNOWN SEARCH for Diabetes in Youth Study
Nov 16, 2017·Inflammatory Bowel Diseases·Jeffrey S HyamsRichard Strauss
Jan 19, 2019·Diabetes Technology & Therapeutics·Nicole C FosterSatish K Garg
Feb 13, 2019·Inflammatory Bowel Diseases·Omoniyi J AdedokunGopi Shankar
Mar 25, 2019·Current Diabetes Reports·Griselda Lim Loo XinDinesh Kumar Chellappan
Sep 29, 2019·International Journal of Molecular Sciences·Miriam Cabello-OlmoMiguel Barajas
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jan 9, 2021·Best Practice & Research. Clinical Endocrinology & Metabolism·Coco M Fuhri SnethlageNordin M J Hanssen
Feb 8, 2021·Diabetologia·Daniel J Drucker
Dec 20, 2020·Biomolecules·Gabriel Brawerman, Peter J Thompson
Feb 3, 2021·The Journal of Clinical Investigation·Anna LamKevan C Herold
Nov 19, 2020·The New England Journal of Medicine·Domenico Accili
Mar 5, 2021·Science Translational Medicine·Emily K SimsUNKNOWN Type 1 Diabetes TrialNet Study Group
Mar 5, 2021·The Lancet. Diabetes & Endocrinology·S Alice Long, Cate Speake
Mar 18, 2021·Reviews in Endocrine & Metabolic Disorders·Natalia G VallianouMaria Dalamaga
Mar 25, 2021·The Journal of Clinical Investigation·Alvin C Powers
May 6, 2021·Diabetes·Teresa Rodriguez-CalvoEmily K Sims
Jul 3, 2021·The Lancet. Diabetes & Endocrinology·Stephen E GitelmanUNKNOWN Gleevec Trial Study Group
Jul 3, 2021·The Lancet. Diabetes & Endocrinology·Jay S Skyler
Jul 2, 2021·Pharmacological Reviews·Leslie S SatinEmily M Walker
Aug 3, 2021·Frontiers in Endocrinology·Peng WangAndrew F Stewart
Jul 31, 2021·Science·Colin M DayanJohn A Todd
Jul 31, 2021·Science·Jeffrey A BluestoneKevan C Herold
Jun 29, 2021·Endocrine Reviews·Steven E KahnC Bruce Verchere
Apr 13, 2021·Endocrine Reviews·John T WalkerAlvin C Powers
Sep 24, 2021·Diabetic Medicine : a Journal of the British Diabetic Association·Danijela Tatovic, Colin M Dayan
Jul 20, 2021·Physiological Reviews·Adam Ramzy, Timothy J Kieffer
Nov 9, 2021·JCI Insight·Carla J GreenbaumUNKNOWN ITN058AI EXTEND Study Team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.